Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleromyxedema.

J J Chanda

    Cutis
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Scleromyxedema, a rare skin disorder, presents with waxy papules and sclerosis. While its cause is unknown, a serum factor may drive skin fibroblast proliferation, and melphalan offers limited, risky treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The clinical recognition and prognostic factors of primary cutaneous malignant melanoma.

    The Medical clinics of North America·1986
    Same author

    Extramammary Paget's disease: prognosis and relationship to internal malignancy.

    Journal of the American Academy of Dermatology·1985
    Same author

    Extramammary Paget's disease and occult hypernephroma.

    Journal of the American Academy of Dermatology·1985
    Same author

    Adverse effect of melanoma incision.

    Journal of the American Academy of Dermatology·1985
    Same author

    Necrotizing vasculitis (angiitis) with granulomatosis.

    International journal of dermatology·1984
    Same author

    Primary granulomatous dermatitis caused by Rhodochrous. Evidence for a pathogenic role in humans.

    Archives of dermatology·1983
    Same journal

    Black Dots on the Scalp of a Child.

    Cutis·2026
    Same journal

    Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

    Cutis·2026
    Same journal

    Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

    Cutis·2026
    Same journal

    The Future of Psoriasis Care.

    Cutis·2026
    Same journal

    Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

    Cutis·2026
    Same journal

    Metastatic Primary Extramammary Paget Disease: A Case Series.

    Cutis·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Rare Diseases
    • Immunology

    Background:

    • Scleromyxedema, also known as lichen myxedematosus or papular mucinosis, is a rare mucopolysaccharide deposition disease.
    • It is characterized by distinctive lichenoid, waxy papules and skin sclerosis.
    • Systemic involvement is exceptionally rare, and the etiology and pathogenesis remain largely unknown.

    Purpose of the Study:

    • To summarize the current understanding of scleromyxedema.
    • To highlight potential pathogenic mechanisms.
    • To review treatment options and their associated risks.

    Main Methods:

    • Literature review of scleromyxedema cases and research.
    • Analysis of reported pathogenic factors.
    • Evaluation of treatment efficacy and safety data.

    Related Experiment Videos

    Main Results:

    • A serum factor has been implicated in promoting skin fibroblast proliferation.
    • Treatment with systemic melphalan shows a 50-60% improvement rate.
    • Significant morbidity and mortality risks are associated with melphalan therapy.

    Conclusions:

    • Scleromyxedema is a rare skin condition with unclear origins.
    • Melphalan may be effective but carries substantial risks, necessitating cautious use.
    • Further research into pathogenesis and safer treatments is warranted.